Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (33)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Hamanaka, H.
Right arrow Articles by Fujita, S. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamanaka, H.
Right arrow Articles by Fujita, S. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2000, Vol. 9, No. 3 353-361
© 2000 Oxford University Press

Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice

Hiroki Hamanaka+, Yuko Katoh-Fukui1, Kazuo Suzuki2, Mariko Kobayashi, Rika Suzuki1, Yoshiko Motegi1, Yoko Nakahara1, Aya Takeshita1, Mizue Kawai2, Koichi Ishiguro, Minesuke Yokoyama1 and Shinobu C. Fujita§

Project 8 and 1Reproductive Engineering Section, Mitsubishi Kasei Institute of Life Sciences, 11 Minamiooya, Machida, Tokyo 194-8511, Japan, 2Pharmaceuticals Research Laboratory 1, Mitsubishi-Tokyo Pharmaceuticals Inc., Yokohama Research Center, 1000 Kamoshida-cho, Aoba-ku, Yokohama 227-8502, Japan

The {varepsilon}4 allele of apolipoprotein E (apoE) is associated with an increased risk of developing Alzheimer’s disease (AD). To accurately determine the isoform-specific effects of human apoE on brain functions under physiological and pathological situations, we created mice expressing human apoE4 isoform in place of mouse apoE by utilizing the gene-targeting technique on the embryonic stem cells (knock-in). The homozygous {varepsilon}4 (4/4) mice correctly expressed human apoE4 in the serum and the brain. The human apoE in the brain was found primarily in the astrocytes as was the mouse apoE in the wild-type (+/+) mice. In the 4/4 mice, the serum cholesterol level was 2.5-fold that of the +/+ littermate controls on a regular diet. This marked elevation was accounted for by an accumulation of very low and low density lipo­proteins. In the brains of the 4/4 mice, however, the amounts of total cholesterol and phospholipids were significantly decreased compared with the +/+ littermates. These findings indicate that cholesterol and lipid metabolism is markedly altered in the 4/4 mice. Our human apoE4 knock-in mice will be useful in clarifying the role of apoE in the etiologies of AD and cardiovascular diseases in relation to cholesterol and lipid metabolism.

+ Present address: Laboratory for Neurodegeneration and Signaling, Brain Science Institute, RIKEN (Institute of Physical and Chemical Research), 2-1 Hirosawa, Wako, Saitama 351-0198, Japan

§ To whom correspondence should be addressed. Tel: +81 42 724 6276; Fax: +81 42 724 6314; Email: fujita@ls.m-kagaku.co.jp


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Annals of Clinical & Laboratory ScienceHome page
T. Yamada, T. Someya, and S. Fujita
Immunotargeting of Apolipoprotein E in Amyloid: An Initial Trial in Mice
Ann. Clin. Lab. Sci., January 1, 2009; 39(2): 134 - 137.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
C-M Lai, S A Dunlop, L A May, M Gorbatov, M Brankov, W-Y Shen, N Binz, Y K. Lai, C E Graham, C J Barry, et al.
Generation of transgenic mice with mild and severe retinal neovascularisation
Br J Ophthalmol, July 1, 2005; 89(7): 911 - 916.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. M. Mann, F. E. Thorngate, Y. Katoh-Fukui, H. Hamanaka, D. L. Williams, S. Fujita, and B. T. Lamb
Independent effects of APOE on cholesterol metabolism and brain A{beta} levels in an Alzheimer disease mouse model
Hum. Mol. Genet., September 1, 2004; 13(17): 1959 - 1968.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J.-S. Gong, M. Kobayashi, H. Hayashi, K. Zou, N. Sawamura, S. C. Fujita, K. Yanagisawa, and M. Michikawa
Apolipoprotein E (ApoE) Isoform-dependent Lipid Release from Astrocytes Prepared from Human ApoE3 and ApoE4 Knock-in Mice
J. Biol. Chem., August 9, 2002; 277(33): 29919 - 29926.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. Lesuisse, G. Xu, J. Anderson, M. Wong, J. Jankowsky, G. Holtz, V. Gonzalez, P. C. Y. Wong, D. L. Price, F. Tang, et al.
Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice
Hum. Mol. Genet., October 1, 2001; 10(22): 2525 - 2537.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. L. Raffai, L.-M. Dong, R. V. Farese Jr., and K. H. Weisgraber
Introduction of human apolipoprotein E4 ""domain interaction"" into mouse apolipoprotein E
PNAS, September 5, 2001; (2001) 201279298.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Morishima-Kawashima, N. Oshima, H. Ogata, H. Yamaguchi, M. Yoshimura, S. Sugihara, and Y. Ihara
Effect of Apolipoprotein E Allele {{epsilon}}4 on the Initial Phase of Amyloid {beta}-Protein Accumulation in the Human Brain
Am. J. Pathol., December 1, 2000; 157(6): 2093 - 2099.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. L. Raffai, L.-M. Dong, R. V. Farese Jr., and K. H. Weisgraber
Introduction of human apolipoprotein E4 "domain interaction" into mouse apolipoprotein E
PNAS, September 25, 2001; 98(20): 11587 - 11591.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.